263 related articles for article (PubMed ID: 27090598)
1. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.
Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL
Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598
[TBL] [Abstract][Full Text] [Related]
2. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
3. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
[TBL] [Abstract][Full Text] [Related]
4. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction.
Griesinger G; Tournaye H; Macklon N; Petraglia F; Arck P; Blockeel C; van Amsterdam P; Pexman-Fieth C; Fauser BC
Reprod Biomed Online; 2019 Feb; 38(2):249-259. PubMed ID: 30595525
[TBL] [Abstract][Full Text] [Related]
6. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle.
Xu H; Zhang XQ; Zhu XL; Weng HN; Xu LQ; Huang L; Liu FH
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102110. PubMed ID: 33727207
[TBL] [Abstract][Full Text] [Related]
7. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?
Griesinger G; Blockeel C; Tournaye H
Fertil Steril; 2018 May; 109(5):756-762. PubMed ID: 29778368
[TBL] [Abstract][Full Text] [Related]
8. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.
Barbosa MWP; Valadares NPB; Barbosa ACP; Amaral AS; Iglesias JR; Nastri CO; Martins WP; Nakagawa HM
JBRA Assist Reprod; 2018 Jun; 22(2):148-156. PubMed ID: 29488367
[TBL] [Abstract][Full Text] [Related]
9. Role of Dydrogesterone for Luteal Phase Support in Assisted Reproduction.
Patki A
Reprod Sci; 2024 Jan; 31(1):17-29. PubMed ID: 37488405
[TBL] [Abstract][Full Text] [Related]
10. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.
Griesinger G; Blockeel C; Kahler E; Pexman-Fieth C; Olofsson JI; Driessen S; Tournaye H
PLoS One; 2020; 15(11):e0241044. PubMed ID: 33147288
[TBL] [Abstract][Full Text] [Related]
11. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
Barbosa MW; Silva LR; Navarro PA; Ferriani RA; Nastri CO; Martins WP
Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
[TBL] [Abstract][Full Text] [Related]
12. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination.
Taş M; Uludag SZ; Aygen ME; Sahin Y
Gynecol Endocrinol; 2020 Jan; 36(1):77-80. PubMed ID: 31464143
[TBL] [Abstract][Full Text] [Related]
14. Dydrogesterone use in early pregnancy.
Mirza FG; Patki A; Pexman-Fieth C
Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
[TBL] [Abstract][Full Text] [Related]
15. A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in
Yang DZ; Griesinger G; Wang W; Gong F; Liang X; Zhang H; Sun Y; Kahler E; Pexman-Fieth C; Olofsson JI; Tournaye H; Chen ZJ
Gynecol Endocrinol; 2020 Feb; 36(2):175-183. PubMed ID: 31397179
[TBL] [Abstract][Full Text] [Related]
16. Vaginal versus intramuscular progesterone for luteal phase support in assisted reproductive techniques: a systematic review and meta-analysis of randomized controlled trials.
Abdelhakim AM; Abd-ElGawad M; Hussein RS; Abbas AM
Gynecol Endocrinol; 2020 May; 36(5):389-397. PubMed ID: 32054365
[TBL] [Abstract][Full Text] [Related]
17. Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
Netter A; Mancini J; Buffat C; Agostini A; Perrin J; Courbiere B
PLoS One; 2019; 14(7):e0220450. PubMed ID: 31361764
[TBL] [Abstract][Full Text] [Related]
18. Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study.
Atzmon Y; Aslih N; Estrada D; Bilgory A; Ellenbogen A; Shalom-Paz E
Reprod Sci; 2021 Jul; 28(7):1874-1881. PubMed ID: 33140324
[TBL] [Abstract][Full Text] [Related]
19. The role of luteal support during IVF: a qualitative systematic review.
Tomic V; Kasum M; Vucic K
Gynecol Endocrinol; 2019 Oct; 35(10):829-834. PubMed ID: 31032676
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N
Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
